Patents by Inventor Thomas F. Bayne

Thomas F. Bayne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Spore-based probiotic composition for modulation of dermal and sub-dermal properties
    Patent number: 11786563
    Abstract: The present invention relates to methods of modulating dermal and sub-dermal properties of a subject. The present invention relates to methods comprising administering to a subject a spore-based probiotic composition.
    Type: Grant
    Filed: September 7, 2021
    Date of Patent: October 17, 2023
    Assignee: Novozymes A/S
    Inventors: Kiran Krishnan, Dale M. Kriz, Thomas F. Bayne
  • SPORE-BASED PROBIOTIC COMPOSITION FOR MODULATION OF DERMAL AND SUB-DERMAL PROPERTIES
    Publication number: 20210401901
    Abstract: The present invention relates to methods of modulating dermal and sub-dermal properties of a subject. The present invention relates to methods comprising administering to a subject a spore-based probiotic composition.
    Type: Application
    Filed: September 7, 2021
    Publication date: December 30, 2021
    Applicant: Novozymes A/S
    Inventors: Kiran Krishnan, Dale M. Kriz, Thomas F. Bayne
  • Spore-based probiotic composition for modulation of dermal and sub-dermal properties
    Patent number: 11129860
    Abstract: The present invention relates to methods of modulating dermal and sub-dermal properties of a subject. The present invention relates to methods comprising administering to a subject a spore-based probiotic composition.
    Type: Grant
    Filed: January 15, 2020
    Date of Patent: September 28, 2021
    Assignee: Novozymes, A/S
    Inventors: Kiran Krishnan, Dale M. Kriz, Thomas F. Bayne
  • SPORE-BASED PROBIOTIC SUPPLEMENTATION IN CHICKENS AND EFFECT ON SALMONELLA LOADS
    Publication number: 20210252078
    Abstract: This disclosure relates to a method of evaluating effects of probiotic supplementation on performance and Salmonella load in broilers challenged with Salmonella enterica serovar Enteritidis, said probiotic containing Bacillus subtilis, Bacillus licheniformis, and a cellulose carrier.
    Type: Application
    Filed: September 16, 2020
    Publication date: August 19, 2021
    Applicant: Microbiome Labs, LLC
    Inventors: Kiran Krishnan, Dale M. Kriz, Thomas F. Bayne
  • SPORE-BASED PROBIOTIC SUPPLEMENTATION IN DOGS AND CONTROL OF ENDOTOXEMIA
    Publication number: 20210128647
    Abstract: The present invention is directed to methods of administering a probiotic composition including Bacillus subtilis, Bacillus licheniformis, and Pediococcus acidilactici to dogs to decrease endotoxemia and improve the digestive process, and related methods.
    Type: Application
    Filed: September 16, 2020
    Publication date: May 6, 2021
    Applicant: Microbiome Labs, LLC
    Inventors: Kiran Krishnan, Dale M. Kriz, Thomas F. Bayne
  • SPORE-BASED PROBIOTIC COMPOSITION FOR MODULATION OF MICROBIOME IN HUMANS
    Publication number: 20210077547
    Abstract: A spore-based probiotic composition is provided that comprises at least one viable probiotic microorganism having a biological or therapeutic effect on microbiome in humans. One exemplary composition contains five different strains of Bacillus spp. Also provided are methods of producing spore-based probiotic compositions. A validated in vitro gut model which is a simulated human intestinal microbial ecosystem reactor was used to assess the long-term effect of the composition on microbial metabolic activity and community composition. The results support use of the composition in protecting against obesity-related disorders, metabolic disorders, inflammation, and cancer, for example. A method for modulating microbial metabolic activity and/or modulating microbial community composition in a human subject is described.
    Type: Application
    Filed: September 14, 2020
    Publication date: March 18, 2021
    Applicant: Microbiome Labs, LLC
    Inventors: Kiran Krishnan, Dale M. Kriz, Thomas F. Bayne
  • SPORE-BASED PROBIOTIC COMPOSITION FOR MODULATION OF DERMAL AND SUB-DERMAL PROPERTIES
    Publication number: 20200330528
    Abstract: The present invention relates to methods of modulating dermal and sub-dermal properties of a subject. The present invention relates to methods comprising administering to a subject a spore-based probiotic composition.
    Type: Application
    Filed: January 15, 2020
    Publication date: October 22, 2020
    Applicant: Microbiome Labs, LLC
    Inventors: Kiran Krishnan, Dale M. Kriz, Thomas F. Bayne